INTRODUCTION
More than two years after the description of the first Covid-19 cases,
our understanding of the clinical impact of SARS-CoV-2 on child health
is significantly improved. Overall, Covid-19 has caused much higher
morbidity and mortality on adults compared with children, although
hospitalizations, severe disease and deaths have been recorded in any
age, including in the youngest children.1,2 Moreover,
children have also suffered from post-acute complications of SARS-CoV-2
infection, including the Multisystem Inflammatory Syndrome and Long
Covid.3-6
The recognition that the large majority of children infected with
SARS-CoV-2 develop only mild symptoms and spontaneously completely
recover poses the challenge to understand the optimal way to
specifically evaluateinfected children, rather than simply translating
adult practice into pediatrics. For example, symptomatic adults assessed
in the emergency department (ED) frequently undergo laboratory
diagnostics and imaging, including chest X-Ray or Computed
Tomography.7 This approach was usually routine
practice in the pre-vaccine era, when the clinical impact of Covid-19 on
adults has been massive, and is now mostly reserved to symptomatic
patients. In children, such an approach does not seem justified. As most
children have a low risk of develop severe disease and vaccinations
further reduce this risk, an approach based on routine traditional
imaging does not seem justified, as it is associated with radiation
exposure and longer waiting times in the pediatric emergency department
(PED).1
In this context, an approach based on safe and rapid point-of-care tools
to evaluate a child with SARS-CoV-2 infection seems to be more
appropriate. As Covid-19 pneumonia mainly affects the peripheral areas
of the lungs, early preliminary studies in both adults and children have
documented that Lung Ultrasound (LUS) can easily detect low respiratory
tract infection (LRTI) during SARS-CoV-2.8 However,
while several adult studies on large cohorts have documented also a
prognostic role of LUS in predicting hospitalizations and severe
outcomes in infected adults, pediatric studies have provided less
conclusive information, as they mostly included a small number of
patients from single centers and without enough patients with
moderate/severe disease. 9-18For these reasons, we
performed this multicenter national study in order to better
characterize the clinical and prognostic role of LUS in children with
Covid-19 assessed in the PED.